The HPV Serology Laboratory provides expertise and leadership on the development, validation, and standardization of serology assays for HPV studies.
The laboratory creates and improves tools that enable scientists to compare data across different vaccines and studies.
The HPV Serology Laboratory combined the former HPV Immunology Laboratory, evolving from a legacy of expertise that stretches back more than two decades.
The HPV Immunology Laboratory was formed in 2001 under the direction of Ligia Pinto, Ph.D., with a mission to provide infrastructure and scientific leadership for studying immune responses to HPV infection and vaccines in large epidemiological cohorts. In response to developments in the field and the need to increase HPV vaccine implementation worldwide, we worked with the NCI, CDC, the Bill and Melinda Gates Foundation, and various other collaborators to identify gaps in the HPV serology field. In response, the HPV Serology Laboratory was established in January 2017.